Detection of Syndecan-1 and heparanase-1 genes in esophageal carcinoma by quantitative RT-PCR

Abstract

OBJECTIVE To quantitatively explore the expression of Syndecan-1 and heparanase-1 in esophageal cancer tissue as well as their relationship with the clinicopathological factors, in order to evaluate their roles in tumor invasion and metastasis. METHODS Real-time fluorescence quantitative PCR (Q-PCR) was used to analyze the expression levels of Syndecan-1 and heparanase-1 genes, participants included 67 cases with esophageal cancers and 32 healthy volunteers. RESULTS The expression of Heparanase-1 gene in esophageal cancers was higher than that in normal esophageal tissue ( P < 0.001), and the expression of Syndecan-1 gene in the normal esophageal tissue was higher compared with esophageal cancers ( P < 0.001). The positive rates of Syndecan-1 and Heparanase-1 gene in esophageal cancer were 13.4% (9/67) and 85.1% (57/67). The expression of Syndecan-1 and Heparanase-1 genes was significantly related to differentiation, depth of infiltration, lymph node metastasis, vessel metastasis, and TNM stages of disease ( P < 0.05). In an attempt to measure the association between the 2 agents, this study found that the expression of Syndecan-1 mRNA had a significantly negative correlation with the expression of Heparanase-1 mRNA by using Spearman rank correlation test (OR = -0.572, P < 0.001). CONCLUSION Syndecan-1 and Heparanase-1 play important roles in the invasion and metastasis of esophageal cancer. The reduction of Syndecan-1 and/or the increase of Heparanase-1 may influence the invasion and metastasis of malignant tumors. Thus the combination assay of Syndecan- and Heparanase-1 may contribute to the diagnosis and treatment of malignant tumors.